Baseline characteristics of the 527 patients in this study.

dataset

posted on 2017-11-06, 18:37 authored by Tomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, Kosaku Nanki, Shinta Mizuno, Makoto Mutaguchi, Yoshihiro Nakazato, Nagamu Inoue, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai

Baseline characteristics of the 527 patients in this study.

History

Usage metrics

PLOS ONE

Categories

Keywords

factor high-dose 5- ASA group disease remission UC patients maintenance therapy 527 UC patients CI dose 5- aminosalicylic acid IBD duration relapse 5- ASA 2- year follow-up

Licence

Exports